Cytokine expression during orthotopic corneal allograft rejection in mice

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 10, 1998, Pages 1953-1957

  Sano, Yotchtro ^a   Osaivci, Hideya ^a   Sotozono, Chie ^a   Kinoshita, Shigcru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; GRAFT REJECTION; IMMUNOMODULATION; MOUSE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CORNEA; CORNEAL TRANSPLANTATION; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-1; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TH1 CELLS; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031714442     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice: evidence that the immune-genetic rules of rejection do not apply. Transplantation. 1992;54:694-703.
2. Sano Y, Ksander BR, Streilein JW. Murine Orthotopic corneal transplantation in high-risk eyes: rejection is dictated by weak rather than strong alloantigens. Invest Ophthalmol Vis Sci. 1997;38:1130-1138.
3. Sonoda Y, Streilein JW. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts. / Immimol. 1993; 150:1727-1734.
4. Sano Y, Ksander BR, Streilein JW. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction. Invest Ophthalmol Vis Sci. 1995;36: 2176-2185.
5. Callanan D, Peeler J, Niederkom JY. Characteristics of rejection of orthotopic corneal allografts in the rat. Transplantation. 1988;45: 437-443.
6. Sotozono C, He J, Matsumoto Y, et al. Cytokine expression in the alkali-burned cornea. Citrr Eye Res. 1997; 16:670-676.
7. Joo CK, Pepose JS, Stuart PM. T-cell mediated responses in a murine model of orthotopic corneal transplantation. Invest Opbthalmol Vis Sci. 1995:36:1530-1540.
8. Cousins S, Trattler W, Streilein JW. Immune privilege and suppression of immunogenic inflammation in the anterior chamber of the eye. Ctirr Eye Res. 1991;10:287-297.
9. Ksander BR, Streilein JW. Failure of infiltrating precursor cytotoxic T cells to acquire direct cytotoxic function in immunologically privileged sites. J Immimol. 1990;145:2057-2063.
10. He Y, Ross J, Niederkorn JY. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Opbtbalmol Vis Set. 1991:32:2723-2728.
11. Niederkom JY, Peeler JS, Mellon J. Phagocytosis of paniculate antigens by corneal epithelial cells stimulates interleukin-1 secretion and migration of Langerhans cells into the central cornea. Regional Immimol. 1989:2:83-90.
12. Dana MR, Yamada J, Streilein JW. Topical interleukin 1 receptor antagonist promotes corneal transplant survival. Transplantation. 1997:63:1501-1507.
13. Torres PF, De Vos AF, Van der Gaag R, Martins B, Kijlstra A. Cytokine mRNA expression during experimental corneal allograft rejection. Exp Eye Res. 1996;63:453-461.